Thymoma with immunodeficiency
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Thymoma with immunodeficiency | |
---|---|
Other names | Good syndrome |
Thymoma with immunodeficiency (also known as "Good syndrome") is a rare disorder that occurs in adults in whom hypogammaglobulinemia, deficient cell-mediated immunity, and thymoma (usually benign) may develop almost simultaneously.[1]: 82 [2] Most reported cases are in Europe, though it occurs globally.[3]
Dr. Robert Good was first to describe the association between thymoma and hypogammaglobulinemia in 1954.[4] Much remains to be understood about its pathogenesis.[5]
Signs and symptoms
Most patients present with an immunodeficient state and recurrent sinopulmonary infections in their 4th or 5th decade of life. The immunodeficiency may occur before or after the diagnosis of a thymoma.[4]
Immunodeficiency involves both deficient humoral and cellular immunity. Patients have low total serum antibodies. The thymoma may inhibit the thymus’s normal role in production of self-tolerant T lymphocytes. These
It is characterized by increased susceptibility to bacterial, viral, and fungal infections.[6] Good Syndrome is associated with other autoimmune conditions including pure red cell aplasia[7] and myasthenia gravis.[4]
Pathogenesis
The cause of Good Syndrome is unknown. It is thought to be an autoimmune process affecting the bone marrow.[3]
Diagnosis
Definition
There are no formal diagnostic criteria.[5] Generally it can be defined as an adult-onset primary immunodeficiency associated with thymoma, hypogammaglobulinemia, diminished B and T cells, and inverted CD4/CD8+ ratio.[2] It has been suggested that Good Syndrome is a subset of common variable immunodeficiency (CVID).[3]
Treatment
The mainstay of treatment consists of thymectomy and immunoglobulin replacement with
The Centers for Disease Control and Prevention recommend pneumococcal, meningococcal, and Hib vaccination in those with diminished humoral and cell-mediated immunity.
Some have advocated prophylaxis with
See also
- Skin lesion
References
- ISBN 0-7216-2921-0.
- ^ S2CID 44472631.
- ^ PMID 20149753.
- ^ PMID 12499426.
- ^ PMID 27497628.
- ^ Grammatikos, A., Bright, P., Pearson, J. et al. Chronic Enteroviral Meningoencephalitis in a Patient with Good’s Syndrome Treated with Pocapavir. J Clin Immunol (2022). https://doi.org/10.1007/s10875-022-01321-6
- PMID 18166782.